SCHEMBL13640205

SCHEMBL13640205

CC(=O)Oc1ccc(C)cc1C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 2/20 0.48
CYP1A2 P05177 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2D6 P10635 1/20 0.48
PKM P14618 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
ADRA1D P25100 1/20 0.48
HTR2C P28335 1/20 0.48
HRH1 P35367 1/20 0.48
ADRA1B P35368 1/20 0.48
DRD3 P35462 1/20 0.48
OPRK1 P41145 1/20 0.48
CHRNA4 P43681 1/20 0.48
HIF1A Q16665 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 2/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29380051 0.87 LMNA (0.57) LMNAL3MBTL1
SCHEMBL250091 0.87 LMNA (0.57) LMNAL3MBTL1
SCHEMBL21790677 0.87 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1RAB9ANPC1LMNA
SCHEMBL10930223 0.83 KDM4E (0.67) ALDH1A1KDM4EL3MBTL1KMT2A
SCHEMBL10438024 0.82 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1RAB9ANPC1LMNA
SCHEMBL11010571 0.82 LMNA (0.48) ADRA1ACYP1A2SMN1; SMN2ALDH1A1LMNA
SCHEMBL11055322 0.82 ELANE (0.49) SMN1; SMN2ALDH1A1RAB9ANPC1LMNA
SCHEMBL487221 0.81 KDM4E (0.54) ADRA1ACYP1A2ADRA2ACYP2D6PKM
SCHEMBL11422437 0.81 CYP3A4 (0.46) ADRA1ACYP1A2ADRA2ACYP2D6PKM
SCHEMBL16710393 0.81 KDM4E (0.45) ADRA1ACYP1A2ADRA2ACYP2D6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics SIGNATURE THERAPEUTICS, INC. 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics GABRP, CYP4F11, CYP2F1 ADRA1A 34/4885CYP1A2 76/4885ADRA2A 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.